Close



Mar 27, 2024 04:30PM
Mar 27, 2024 04:30PM
Mar 7, 2024 04:30PM
Feb 13, 2024 04:18PM
Feb 13, 2024 04:18PM
Dec 3, 2019 09:15AM
Dec 3, 2019 08:48AM Merrimack Pharma (MACK) Declares Approximately $0.50 Special Dividend; Approximately 13.3% Yield
Dec 3, 2019 08:45AM
Sep 19, 2019 09:00AM
Sep 5, 2019 09:15AM
Aug 26, 2019 09:00AM
Jul 25, 2019 08:30AM
May 30, 2019 04:34PM
May 30, 2019 04:05PM Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones and Special Cash Dividend
Nov 7, 2018 06:45AM
Aug 7, 2018 06:30AM
Mar 12, 2018 06:27AM
Nov 8, 2017 06:40AM
Oct 10, 2017 04:24PM
Oct 10, 2017 04:24PM
Aug 9, 2017 06:55AM Merrimack Reports Second Quarter 2017 Financial Results
Aug 3, 2017 04:05PM
Jun 29, 2017 06:00AM
May 10, 2017 06:45AM
May 4, 2017 04:05PM
Apr 5, 2017 04:11PM
Apr 5, 2017 04:05PM
Apr 3, 2017 11:41AM Merrimack Pharma (MACK) Launches New R&D Entity with Ipsen SA (IPSEY) Following Completion of $1B ONIVYDE® Deal
Apr 3, 2017 11:30AM
Mar 30, 2017 12:01PM
Mar 30, 2017 12:00PM
Mar 1, 2017 07:00AM
Feb 23, 2017 04:10PM
Jan 18, 2017 07:35AM
Jan 18, 2017 07:30AM Merrimack Names Richard Peters, M.D., Ph.D., as President and CEO
Jan 9, 2017 06:20AM
Jan 8, 2017 09:45PM
Jan 8, 2017 07:45PM
Nov 19, 2014 05:25PM
Nov 19, 2014 09:32AM

378,383 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All